3U HOLDING AG published its annual report for fiscal year 2010

.
– Revenue as expected declined to EUR 82.4 million
– Earnings increased to EUR 5.83 million
– EBITDA decreased to EUR 6.42 million due to one-time special items
– Equity ratio increased to 51.76%
– Positive start to the year 2011 – Positive outlook confirmed
– Proposed dividend of EUR 0.02
3U HOLDING AG (ISIN DE0005167902) today published its annual report for fiscal year 2010.
Group sales expectedly decreased significantly from

Gartner Says by 2015, Digital Strategies, Such as Social and Mobile Marketing, Will Influence at Least 80 Per Cent of Consumers- Discretionary Spending

.2011 – A digital marketing approach and its associated channels are critical for overcoming the declining effectiveness of mass marketing, according to Gartner, Inc. Although marketers have been using digital channels as part of their campaign management strategies for more than ten years, most are using them for traditional push, mass-marketed, interruption-type execution of campaigns rather than a two-way engagement approach.
"Mass marketing is no longer a long-term strategy. Mas

ATLAS Biolabs certified for innovative exome enrichment technology from Roche NimbleGen

ATLAS Biolabs certified for innovative exome enrichment technology from Roche NimbleGen

Berlin, March 29, 2011 – ATLAS Biolabs GmbH has become the second service provider in Europe to be certified for SeqCap EZ Exome and SeqCap EZ Choice enrichment technology from Roche NimbleGen. The new technology allows the targeted enrichment and subsequent sequencing of the human exome, i.e. of all genomic DNA sequences that carry the genetic blueprint encoding the body-s proteins. ATLAS Biolabs is thus expanding its range of services in the field of DNA enrichment. Only recently, the company